Page 109 - 《中国药房》2025年12期
P. 109

“互联网+”藏语用药服务平台的构建及应用效果评价                                                           Δ



                *
          刘 嫚 ,杨 亮,王琳玲,欧亚青,程 铃,王良芬,王应强,唐小婷,陈 蓉(三六三医院药剂科,成都
                                                                                  #
          610041)


          中图分类号  R952;R969.3      文献标志码  A      文章编号  1001-0408(2025)12-1515-05
          DOI  10.6039/j.issn.1001-0408.2025.12.17


          摘  要  目的  构建“互联网+”藏语用药服务平台,评价其对藏族慢病患者用药依从性及安全性的影响。方法  对我院门诊常用药
          品进行用药指导内容的归纳与整理,翻译成藏语并进行藏语录音或藏语视频录制,形成“文字-语音-视频”多维度的“互联网+”藏
          语用药服务平台并应用。选取我院“互联网+”藏语用药服务实施后(2024年1-6月)的门诊藏族慢病患者387例作为干预组,实
          施前(2023年1-6月)的门诊藏族慢病患者387例作为对照组,对照组患者接受常规窗口汉语用药服务,干预组患者接受常规窗
          口汉语用药服务和“互联网+”藏语用药服务。采用12条目用药依从性量表评估患者的用药依从性;采用国家药物不良反应监测
          中心药物不良反应分析原则进行六级关联性评价,并对关联性评价结果为“肯定”“很可能”“可能”的不良反应的发生情况进行统
          计。结果  干预组用药依从性良好的患者比例(31.0%)及依从性得分[39.0(37.0,42.0)]均显著优于对照组[7.0%、21.0(19.0,23.0)]
         (P<0.05),两组患者的各类不良反应发生率及总发生率比较,差异均无统计学意义(P>0.05)。结论  成功构建“互联网+”藏语用
          药服务平台;该服务可提高藏族慢病患者的用药依从性,但在改善患者用药安全性方面的效果有限。
          关键词  互联网+;藏语用药服务;藏族患者;用药依从性;安全性;慢病管理


          Construction and application effect of “internet+” Tibetan-language medication service platform
          LIU Man,YANG Liang,WANG Linling,OU Yaqing,CHENG Ling,WANG Liangfen,WANG Yingqiang,
          TANG Xiaoting,CHEN Rong(Dept. of Pharmacy, 363 Hospital, Chengdu 610041, China)

          ABSTRACT   OBJECTIVE  To  build  a Tibetan-language  medication  service  platform  based  on “internet+”  and  evaluate  its  effect
          on improving medication compliance and safety of Tibetan patients with chronic disease. METHODS Medication guidance contents
          of  commonly  used  drugs  in  the  outpatient  department  were  summarized,  translated  and  recorded  in  Tibetan-language  or  video  to
          form  a “text-audio-video”  multi-dimensional “internet+ ”  Tibetan-language  medication  service  platform.  A  total  of  387  Tibetan
          outpatients with chronic disease in our hospital after the implementation of “internet+” Tibetan-language medication service platform
         (from  January  2024  to  June  2024)  in  our  hospital  were  selected  as  the  intervention  group,  and  387 Tibetan  outpatients  before  the
          implementation (from  January  2023  to  June  2023)  were  selected  as  the  control  group.  Patients  in  the  control  group  received
          conventional  window-based  Chinese-language  medication  services,  while  patients  in  the  intervention  group  received  both
          conventional  window-based  Chinese-language  medication  service  and “internet+ ”  Tibetan-language  medication  service.  The
          medication  compliance  of  patients  was  evaluated  using  the  12-item  Medication  Compliance  Scale. A  six-level  causality  assessment
          was  conducted  as  the  principles  for  analyzing  adverse  drug  reactions (ADR)  set  by  the  National  Center  for  ADR  Monitoring.
          Additionally,  statistics  were  compiled  on  the  occurrence  of ADR  that  were  assessed  as “definite”“probable”  or “possible”  in  the
          causality assessment. RESULTS The proportion (31.0%) of patients with good medication compliance and compliance scores [39.0
         (37.0,42.0)] of patients in the intervention group were significantly better than control group [7.0%, 21.0(19.0, 23.0)] (P<0.05).
          There were no statistically significant differences in the incidence of various types of ADR or the overall incidence between the two
          groups (P>0.05). CONCLUSIONS The “internet+” Tibetan-language medication service platform is constructed successfully; the
          service can effectively improve the medication compliance of Tibetan-language patients, but its effect on improving the medication
                                                             safety of patients is limited.
             Δ 基金项目 国家卫生健康委医院管理研究所医院药学高质量发
          展研究项目(No.NIHAYS2301)                               KEYWORDS “internet+”; Tibetan-language medication service;
             *第一作者 主管药师,硕士。研究方向:临床药学。E-mail:                 Tibetan  patients;  medication  compliance;  safety;  chronic
          6796766@qq.com                                     disease management
             # 通信作者 主任药师,硕士。研究方向:临床药学。E-mail:
          894846142@qq.com


          中国药房  2025年第36卷第12期                                              China Pharmacy  2025 Vol. 36  No. 12    · 1515 ·
   104   105   106   107   108   109   110   111   112   113   114